More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...
Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...
A next-generation biomarker-based blood test demonstrated 98% specificity and 75% sensitivity in detecting stage I and II pancreatic ductal adenocarcinoma, according to a press release from the ...
Blood tests can be an important part of a pancreatic cancer diagnosis. With this type of cancer, a timely diagnosis is vital, however, pancreatic cancer is often difficult to detect early. Certain ...
Please provide your email address to receive an email when new articles are posted on . The blood test reliably detected patients with stage I and II pancreatic ductal adenocarcinoma with 97% accuracy ...
Scientists are developing a test that uses a tiny blood sample to detect pancreatic cancer in its early stages. If caught early, pancreatic cancer can potentially be treated. However, patients usually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results